Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 05 Sep 2022

EML4-ALK rearrangement in primary malignant fibrous histiocytoma of the lung treated with alectinib: A case report

in Thoracic Oncology

Shuai Zhang
Xuqiang Liao
Jiawei Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.978327

1,611 views
2 citations

Original Research

Published on 02 Sep 2022

Deep learning analysis to predict EGFR mutation status in lung adenocarcinoma manifesting as pure ground-glass opacity nodules on CT

in Thoracic Oncology

Hyun Jung Yoon
Jieun Choi
Eunjin Kim
Sang-Won Um
Noeul Kang
Wook Kim
Geena Kim
Hyunjin Park
Ho Yun Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.951575

4,689 views
13 citations

Original Research

Published on 02 Sep 2022

Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study

in Thoracic Oncology

Yong-sheng Cai
Hong-hong Dong
Xin-yang Li
Xin Ye
Shuo Chen
Bin Hu
Hui Li
Jin-bai Miao
Qi-rui Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.976988

2,662 views
1 citation

Original Research

Published on 02 Sep 2022

Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations

in Thoracic Oncology

Chao Shi
Ruyue Xing
Mengmeng Li
Junnan Feng
Rui Sun
Bing Wei
Yongjun Guo
Jie Ma
Huijuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.949304

5,929 views
15 citations

Case Report

Published on 02 Sep 2022

PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review

in Thoracic Oncology

Na Yin
Xiangliang Liu
Xiaojun Ye
Wei Song
Jin Lu
Xiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.961266

4,060 views
7 citations

Systematic Review

Published on 02 Sep 2022

Acupuncture for adult lung cancer of patient-reported outcomes: A systematic review and meta-analysis

in Thoracic Oncology

Ziqi Xi
Xuqiang Wei
Zi Ye
Ke Wang
Jia Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.921151

14,695 views
14 citations

Original Research

Published on 31 Aug 2022

Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis

in Thoracic Oncology

Ke Zhou
Yaqin Zhao
Linchuan Liang
Jie Cao
Huahang Lin
Zhiyu Peng
Jiandong Mei

Frontiers in Oncology

doi 10.3389/fonc.2022.938195

2,945 views
11 citations

Case Report

Published on 30 Aug 2022

Pseudo-progression with osimertinib after definitive chemoradiation in unresectable epidermal growth factor receptor mutation positive of stage III non-small cell lung cancer: A case report

in Thoracic Oncology

Fei Ren
Yao Wang
Yongsheng Gao
Xiangjiao Meng

Frontiers in Oncology

doi 10.3389/fonc.2022.971192

3,778 views
1 citation

Original Research

Published on 30 Aug 2022

Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma

in Thoracic Oncology

Long Shu
Shuang Liu
Yongguang Tao

Frontiers in Oncology

doi 10.3389/fonc.2022.902353

4,817 views
6 citations

Review

Published on 30 Aug 2022

Lurbinectedin in small cell lung cancer

in Thoracic Oncology

Anna Manzo
Vincenzo Sforza
Guido Carillio
Giuliano Palumbo
Agnese Montanino
Claudia Sandomenico
Raffaele Costanzo
Giovanna Esposito
Francesca Laudato
Edoardo Mercadante

Frontiers in Oncology

doi 10.3389/fonc.2022.932105

18,725 views
24 citations

Brief Research Report

Published on 30 Aug 2022

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions

in Thoracic Oncology

Yuan Qiu
Liping Liu
Haihong Yang
Hanzhang Chen
Qiuhua Deng
Dakai Xiao
Yongping Lin
Changbin Zhu
Weiwei Li
Di Shao

Frontiers in Oncology

doi 10.3389/fonc.2022.952572

3,046 views
4 citations

Original Research

Published on 30 Aug 2022

Systematic assessment of microRNAs associated with lung cancer and physical exercise

in Thoracic Oncology

Yang Liu
Libo He
Wang Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.917667

3,399 views
8 citations

Review

Published on 30 Aug 2022

Solitary extramedullary plasmacytoma in the lung misdiagnosed as lung cancer: A case report and literature review

in Thoracic Oncology

Jingjing Wang
Xiaoyun Yang
Xiaomei Liu
Tao He
Bin Liu
Lei Yang
Fei Yuan
Jing Li

Frontiers in Oncology

doi 10.3389/fonc.2022.950383

5,820 views
7 citations

Original Research

Published on 26 Aug 2022

3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies

in Thoracic Oncology

Huaikai Shi
Emma M. Rath
Ruby C. Y. Lin
Kadir Harun Sarun
Candice Julie Clarke
Brian C. McCaughan
Helen Ke
Anthony Linton
Kenneth Lee
Sonja Klebe

Frontiers in Oncology

doi 10.3389/fonc.2022.973576

6,115 views
18 citations

Systematic Review

Published on 26 Aug 2022

Cost-Effectiveness of Pembrolizumab for the treatment of Non–Small-Cell lung cancer: A systematic review

in Thoracic Oncology

Chuan Zhang
Jiaxu Zhang
Jing Tan
Panwen Tian
Weimin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.815587

7,142 views
11 citations

Review

Published on 26 Aug 2022

Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China

in Thoracic Oncology

Takaaki Mizuno
Yuki Katsuya
Jun Sato
Takafumi Koyama
Toshio Shimizu
Noboru Yamamoto

Frontiers in Oncology

doi 10.3389/fonc.2022.925938

12,342 views
16 citations

Original Research

Published on 26 Aug 2022

Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer

in Thoracic Oncology

Yahan Huang
Jiao Wang
Yanting Hu
Pikun Cao
Gang Wang
Hongchao Cai
Meixiang Wang
Xia Yang
Zhigang Wei
Xin Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.938827

4,295 views
19 citations

Systematic Review

Published on 25 Aug 2022

Parotid metastases from primary lung cancer: Case series and systematic review of the features

in Thoracic Oncology

Rulan Wang
Ting Wang
Qinghua Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.963094

8,108 views
5 citations

Original Research

Published on 25 Aug 2022

Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study

in Thoracic Oncology

Long Liang
Zixuan Liu
Changhui Wang
Shuanshuan Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.940839

2,704 views
6 citations

Original Research

Published on 24 Aug 2022

Pulmonary mucoepidermoid carcinoma in the Chinese population: A clinical characteristic and prognostic analysis

in Thoracic Oncology

Qiuyu Li
Xuejing Wei
Yanfei Wang
Chang Liu
Boshi Fan
Cheng Lv
Wenzhe Si
Min Li

Frontiers in Oncology

doi 10.3389/fonc.2022.916906

3,729 views
6 citations

Correction

Published on 24 Aug 2022

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

in Thoracic Oncology

Yin Yang
Jianyang Wang
Wenqing Wang
Tao Zhang
Jingjing Zhao
Yu Wang
Yexiong Li
Luhua Wang
Nan Bi

Frontiers in Oncology

doi 10.3389/fonc.2022.1007862

1,708 views
4 citations

Original Research

Published on 24 Aug 2022

Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

in Thoracic Oncology

Ni Zhao
Ye Yi
Wen Cao
Xiao Fu
Nan Mei
Chunli Li

Frontiers in Oncology

doi 10.3389/fonc.2022.923531

6,808 views
18 citations

Original Research

Published on 23 Aug 2022

Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis

in Thoracic Oncology

Wei-Yu Yang
Yu He
Qikang Hu
Muyun Peng
Zhe Zhang
Shouzhi Xie
Fenglei Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.984932

3,071 views
6 citations

Original Research

Published on 23 Aug 2022

Microwave ablation therapy assisted by artificial pneumothorax and artificial hydrothorax for lung cancer adjacent to the vital organs

in Thoracic Oncology

Jian Chen
Liqin Qi
Jin Chen
Qingfeng Lin
Yuan Yan
Jie Chen
Zhengyu Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.981789

3,378 views
6 citations

1,912 articles

articles

EML4-ALK rearrangement in primary malignant fibrous histiocytoma of the lung treated with alectinib: A case report

Deep learning analysis to predict EGFR mutation status in lung adenocarcinoma manifesting as pure ground-glass opacity nodules on CT

Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study

Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations

PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review

Acupuncture for adult lung cancer of patient-reported outcomes: A systematic review and meta-analysis

Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis

Pseudo-progression with osimertinib after definitive chemoradiation in unresectable epidermal growth factor receptor mutation positive of stage III non-small cell lung cancer: A case report

Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma

Lurbinectedin in small cell lung cancer

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions

Systematic assessment of microRNAs associated with lung cancer and physical exercise

Solitary extramedullary plasmacytoma in the lung misdiagnosed as lung cancer: A case report and literature review

3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies

Cost-Effectiveness of Pembrolizumab for the treatment of Non–Small-Cell lung cancer: A systematic review

Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China

Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer

Parotid metastases from primary lung cancer: Case series and systematic review of the features

Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study

Pulmonary mucoepidermoid carcinoma in the Chinese population: A clinical characteristic and prognostic analysis

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis

Microwave ablation therapy assisted by artificial pneumothorax and artificial hydrothorax for lung cancer adjacent to the vital organs